233 related articles for article (PubMed ID: 3081925)
1. Corticotropin-releasing factor potentiates acoustic startle in rats: blockade by chlordiazepoxide.
Swerdlow NR; Geyer MA; Vale WW; Koob GF
Psychopharmacology (Berl); 1986; 88(2):147-52. PubMed ID: 3081925
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of acoustic startle by corticotropin-releasing factor (CRF) and by fear are both reversed by alpha-helical CRF (9-41).
Swerdlow NR; Britton KT; Koob GF
Neuropsychopharmacology; 1989 Dec; 2(4):285-92. PubMed ID: 2610824
[TBL] [Abstract][Full Text] [Related]
3. Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice.
Risbrough VB; Hauger RL; Pelleymounter MA; Geyer MA
Psychopharmacology (Berl); 2003 Nov; 170(2):178-87. PubMed ID: 12845406
[TBL] [Abstract][Full Text] [Related]
4. Alphaxalone, a steroid anesthetic, inhibits the startle-enhancing effects of corticotropin releasing factor, but not strychnine.
Swerdlow NR; Britton KT
Psychopharmacology (Berl); 1994 Jun; 115(1-2):141-6. PubMed ID: 7862886
[TBL] [Abstract][Full Text] [Related]
5. Corticotropin-releasing factor: long-lasting facilitation of the acoustic startle reflex.
Liang KC; Melia KR; Miserendino MJ; Falls WA; Campeau S; Davis M
J Neurosci; 1992 Jun; 12(6):2303-12. PubMed ID: 1351540
[TBL] [Abstract][Full Text] [Related]
6. Lesions of the central nucleus of the amygdala, but not the paraventricular nucleus of the hypothalamus, block the excitatory effects of corticotropin-releasing factor on the acoustic startle reflex.
Liang KC; Melia KR; Campeau S; Falls WA; Miserendino MJ; Davis M
J Neurosci; 1992 Jun; 12(6):2313-20. PubMed ID: 1607942
[TBL] [Abstract][Full Text] [Related]
7. Interactions between corticotropin-releasing factor and the serotonin 1A receptor system on acoustic startle amplitude and prepulse inhibition of the startle response in two rat strains.
Conti LH
Neuropharmacology; 2012 Jan; 62(1):256-63. PubMed ID: 21835187
[TBL] [Abstract][Full Text] [Related]
8. Corticotropin-releasing factor (CRF) and α 2 adrenergic receptors mediate heroin withdrawal-potentiated startle in rats.
Park PE; Vendruscolo LF; Schlosburg JE; Edwards S; Schulteis G; Koob GF
Int J Neuropsychopharmacol; 2013 Sep; 16(8):1867-75. PubMed ID: 23590881
[TBL] [Abstract][Full Text] [Related]
9. Repeated stress, like vasopressin, sensitizes the excitatory effects of corticotropin releasing factor on the acoustic startle reflex.
Pelton GH; Lee Y; Davis M
Brain Res; 1997 Dec; 778(2):381-7. PubMed ID: 9459555
[TBL] [Abstract][Full Text] [Related]
10. Corticotropin-releasing factor has an anxiogenic action in the social interaction test.
Dunn AJ; File SE
Horm Behav; 1987 Jun; 21(2):193-202. PubMed ID: 2886414
[TBL] [Abstract][Full Text] [Related]
11. Effect of corticosterone on the enhancement of the acoustic startle reflex by corticotropin releasing factor (CRF).
Lee Y; Schulkin J; Davis M
Brain Res; 1994 Dec; 666(1):93-8. PubMed ID: 7889373
[TBL] [Abstract][Full Text] [Related]
12. Centrally administered corticotropin-releasing hormone and peripheral injections of strychnine hydrochloride potentiate the acoustic startle response in preweanling rats.
Weber M; Richardson R
Behav Neurosci; 2001 Dec; 115(6):1273-82. PubMed ID: 11770058
[TBL] [Abstract][Full Text] [Related]
13. Progesterone attenuates corticotropin-releasing factor-enhanced but not fear-potentiated startle via the activity of its neuroactive metabolite, allopregnanolone.
Toufexis DJ; Davis C; Hammond A; Davis M
J Neurosci; 2004 Nov; 24(45):10280-7. PubMed ID: 15537900
[TBL] [Abstract][Full Text] [Related]
14. Effects of corticotropin-releasing factor on prepulse inhibition of the acoustic startle response in two rat strains.
Conti LH; Murry JD; Ruiz MA; Printz MP
Psychopharmacology (Berl); 2002 May; 161(3):296-303. PubMed ID: 12021833
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of the CRF-R1 antagonist GSK876008 on fear-potentiated, light- and CRF-enhanced startle suggest preferential involvement in sustained vs phasic threat responses.
Walker D; Yang Y; Ratti E; Corsi M; Trist D; Davis M
Neuropsychopharmacology; 2009 May; 34(6):1533-42. PubMed ID: 19078950
[TBL] [Abstract][Full Text] [Related]
16. Corticotropin releasing factor and amphetamine exaggerate partial agonist properties of benzodiazepine antagonist Ro 15-1788 in the conflict test.
Britton KT; Lee G; Koob GF
Psychopharmacology (Berl); 1988; 94(3):306-11. PubMed ID: 3128805
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the effects of corticotropin-releasing factor on prepulse inhibition of the acoustic startle response in Brown Norway and Wistar-Kyoto rats.
Conti LH
Eur J Pharmacol; 2005 Jan; 507(1-3):125-34. PubMed ID: 15659302
[TBL] [Abstract][Full Text] [Related]
18. Effects of chlordiazepoxide on footshock- and corticotropin-releasing factor-induced increases in cortical and hypothalamic norepinephrine secretion in rats.
Swiergiel AH; Li Y; Wei ZY; Dunn AJ
Neurochem Int; 2008 May; 52(6):1220-5. PubMed ID: 18280616
[TBL] [Abstract][Full Text] [Related]
19. Modulation of the acoustic startle reflex by infusion of corticotropin-releasing hormone into the nucleus reticularis pontis caudalis.
Birnbaum SG; Davis M
Brain Res; 1998 Jan; 782(1-2):318-23. PubMed ID: 9519280
[TBL] [Abstract][Full Text] [Related]
20. Light-enhanced and fear-potentiated startle: temporal characteristics and effects of alpha-helical corticotropin-releasing hormone.
de Jongh R; Groenink L; van der Gugten J; Olivier B
Biol Psychiatry; 2003 Nov; 54(10):1041-8. PubMed ID: 14625146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
